|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
65.74(B) |
Last
Volume: |
1,691,719 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Delorefice Christopher |
EVP & CFO |
|
2022-09-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(506) |
9,135 |
|
- |
|
Byrd Richard |
EVP & President Interventional |
|
2022-09-06 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
3,750 |
|
- |
|
Garrison Michael David |
EVP and President MedicalOffic |
|
2022-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,477 |
|
1% |
|
Byrd Richard |
EVP & President Interventional |
|
2022-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,724 |
|
1% |
|
Delorefice Christopher |
EVP & CFO |
|
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,674 |
9,641 |
|
- |
|
Hickey David |
EVP & President, Life Sciences |
|
2022-08-15 |
4 |
AS |
$265.00 |
$125,875 |
D/D |
(475) |
3,331 |
|
-4% |
|
Polen Thomas E Jr |
Chairman, CEO and President |
|
2022-08-15 |
4 |
AS |
$265.13 |
$2,518,735 |
D/D |
(9,500) |
28,878 |
|
-4% |
|
Polen Thomas E Jr |
Chairman, CEO and President |
|
2022-08-15 |
4 |
D |
$265.13 |
$1,458,215 |
D/D |
(5,500) |
38,378 |
|
- |
|
Polen Thomas E Jr |
Chairman, CEO and President |
|
2022-08-15 |
4 |
OE |
$167.91 |
$2,518,650 |
D/D |
15,000 |
43,878 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2022-08-09 |
4 |
AS |
$260.00 |
$429,520 |
D/D |
(1,652) |
28,878 |
|
-2% |
|
Polen Thomas E Jr |
Executive Vice President |
|
2022-08-09 |
4 |
D |
$260.00 |
$564,980 |
D/D |
(2,173) |
30,530 |
|
- |
|
Polen Thomas E Jr |
Executive Vice President |
|
2022-08-09 |
4 |
OE |
$147.68 |
$564,876 |
D/D |
3,825 |
32,703 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2022-08-09 |
4 |
D |
$260.44 |
$2,691,647 |
D/D |
(10,335) |
13,223 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2022-08-09 |
4 |
OE |
$93.49 |
$2,691,272 |
D/D |
26,815 |
18,417 |
|
- |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2022-08-09 |
4 |
AS |
$260.44 |
$2,392,141 |
D/D |
(9,185) |
5,928 |
|
-2% |
|
Khichi Samrat S. |
EVP and General Counsel |
|
2022-08-08 |
4 |
AS |
$260.44 |
$1,899,910 |
D/D |
(7,295) |
5,928 |
|
-3% |
|
Grover Rishi |
EVP and Chief ISC Officer |
|
2022-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,340 |
9,439 |
|
- |
|
Grover Rishi |
EVP and Chief ISC OfficerOffic |
|
2022-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
99 |
|
-10% |
|
Mocherla Pavan Kumar |
EVP and President Greater Asia |
|
2022-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
714 |
|
-9% |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2022-07-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
414 |
1,472 |
|
- |
|
Spoerel Thomas J |
VP Controller & Chief Acct Off |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
420 |
1,478 |
|
- |
|
Lim James C |
Executive Vice President |
|
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,280 |
23,941 |
|
- |
|
Hickey David |
EVP & President, Life Sciences |
|
2022-05-06 |
4 |
S |
$256.00 |
$121,600 |
D/D |
(475) |
3,806 |
|
1% |
|
Neal Shana Carol |
Chief People OfficerOfficer |
|
2022-04-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
74 |
|
-1% |
|
Neal Shana Carol |
Chief Human Resources Officer |
|
2022-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,525 |
7,599 |
|
- |
|
863 Records found
|
|
Page 5 of 35 |
|
|